This document is page 46 of a 'Cannabis Investment Report' dated December 2017, published by Ackrell Capital, LLC. The text provides an industry overview of 'Cannabis Flower' and 'Concentrates,' discussing product types, strains (e.g., Blue Dream, OG Kush), and THC content. It appears to be part of a larger document dump collected by the House Oversight Committee (Bates stamp HOUSE_OVERSIGHT_024682), likely included in evidence files, though the specific page contains no direct references to Epstein or his associates.
This document appears to be page 141 of a report titled 'Top 100 Private Cannabis Companies 2018' produced by Ackrell Capital. It lists profiles for four companies: Beboe, Berkeley Patients Group, BioTrackTHC, and Bloom Farms. The document bears a 'HOUSE_OVERSIGHT_024777' Bates stamp, indicating it was part of a production of documents to the House Oversight Committee, likely related to a broader financial investigation.
This document is page 138 from a December 2017 Cannabis Investment Report produced by Ackrell Capital. It lists the 'Top 100 Private Cannabis Companies' for 2018, categorized alphabetically across four columns. The document bears a 'HOUSE_OVERSIGHT_024774' stamp, indicating it is part of a House Oversight Committee investigation file.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity